Stockreport

IGM Biosciences Announces First Quarter 2024 Financial Results and Provides Corporate Update

IGM Biosciences, Inc.  (IGMS) 
Last igm biosciences, inc. earnings: 3/26 04:05 pm Check Earnings Report
PDF - Enrollment target exceeded in aplitabart randomized colorectal cancer clinical trial - - Enrollment completed in first dose cohort in imvotamab rheumatoid arthritis c [Read more]